Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative study of inhaled ciclesonide versus placebo in children with persistent asthma
2006-000803-40Phase 3Completed
- Sponsor
- Nycomed
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclesonide in asthma (8 arms), sponsored by Nycomed. Primary endpoint: Morning peak expiratory flow (PEF) change. Started Jun 2006; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-000803-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000803-40.